Prediction of the Risk of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide
- 13 April 2011
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 32 (8) , 1106-1109
Abstract
Kawasaki disease (KD) is an acute systemic vasculitis associated with the development of coronary arterial lesions (CALs) occurring in 3–5% of children treated by intravenous immune globulin (IVIG). However, a considerable number of patients who are not responding to IVIG are at much higher risk. Although studies have explored potential biomarkers to predict patients with KD who are at risk of CAL, no useful single marker exists. We hypothesized that the serum concentrations of the N-terminal moiety of brain natriuretic peptide (NT-proBNP) can be useful to predict CAL. Forty-three children with KD (29 males and 14 females) were enrolled in this study. Despite IVIG, 6 of the 43 patients developed CAL. There were, however, no significant differences in variables between children with CAL and those without CAL: These include age, gender, day of the illness, leukocyte count, and the serum levels of sodium, C-reactive protein, and albumin. The serum NT-proBNP level was significantly higher in children with CAL than those without CAL (2,611 ± 1,699 vs. 1,073 ± 1,427 pg/ml; P = 0.03): the cutoff value of 1,000 pg/ml to predict CAL produced a specificity of 0.68, sensitivity of 0.83, and an odds ratio as high as 10.4. In conclusion, NT-proBNP is increased in KD patients who are developing CAL, and patients with an elevated serum NT-proBNP >1,000 pg/ml have a risk of CAL ~10 times higher than that of patients with a modest increase.Keywords
This publication has 18 references indexed in Scilit:
- Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki DiseasePediatric Cardiology, 2009
- Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on ageEuropean Journal of Pediatrics, 2009
- The Riddle of Kawasaki DiseaseNew England Journal of Medicine, 2007
- Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki DiseaseCirculation, 2006
- Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki diseaseActa Paediatrica, 2006
- Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Diastolic Dysfunction in Children with Kawasaki DiseasePediatric Cardiology, 2005
- Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki diseasePediatrics International, 2004
- A Predictive Instrument for Coronary Artery Aneurysms in Kawasaki Disease 11This study was supported, in part, by grants HL34545 and HL48606 from the National Institutes of Health, Bethesda, Maryland, and by the Kobren Fund, Boston, Massachusetts.The American Journal of Cardiology, 1998
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993